A detailed history of Nisa Investment Advisors, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 278 shares of SMMT stock, worth $5,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares
278
Previous 278 -0.0%
Holding current value
$5,190
Previous $2,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$2.39 - $10.92 $449 - $2,052
188 Added 208.89%
278 $2,000
Q1 2024

May 01, 2024

BUY
$2.55 - $5.07 $229 - $456
90 New
90 $0
Q3 2023

Nov 02, 2023

SELL
$1.54 - $2.42 $6 - $9
-4 Reduced 4.26%
90 $0
Q2 2023

Aug 11, 2023

BUY
$1.32 - $2.81 $124 - $264
94 New
94 $0

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.76B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.